Four neuroblastoma cell lines were included based on the presence of the most common mutations affecting the RAS-MAPK pathway, RAS (KRAS in SJNB8 and NRAS in SKNAS), NF1 (SKNBE) and ALK (KCNR). This evidence concerns the gene ALK and neuroblastoma.